Lipidomics- and cytokine analyses in obese patients in Primary arthroplasty - outcome corrrelation and Evaluation of predictive markers

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00013550

Enrollment

100

Registered

2017-12-15

Start date

2018-01-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effects of obesity on the outcome of patients with primary knee or hip joint total endoprosthesis are investigated. E66 Z96.64 Z96.65

Interventions

Group 1: Obese patients with primary hip oder knee arthroplasty: Assessment (NRS, SF-MNA, MNA, BMI, HSS/KSS) during stay and 3 months postoperatively as well preoperative blood sample (cytokines, PL/F

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Obesity and non-obesity (regular BMI), primary THA or TKA

Exclusion criteria

Exclusion criteria: dementia, incapability of consent

Design outcomes

Primary

Measure	Time frame
Adverse events / during stay and after three months / Hospital Information System and assessment	—

Secondary

Measure	Time frame
Preoperative: Blood Parameters, functional Status (HHS, KSS) Hospital stay: LOS Postoperative: Functional outcome (HHS, KSS), HRQL (SF-36), pain	—

Countries

Germany

Contacts

Public ContactAnna Schreiner

SWI der BGU Tübingen

aschreiner@bgu-tuebingen.de07071856571

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026